Abstract
Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Current Pharmaceutical Design
Title: Cytokine Therapeutics for Infectious Diseases
Volume: 6 Issue: 6
Author(s): F. H. Rodriguez, S. Nelson and J. K. Kolls
Affiliation:
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Abstract: Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Export Options
About this article
Cite this article as:
Rodriguez H. F., Nelson S. and Kolls K. J., Cytokine Therapeutics for Infectious Diseases, Current Pharmaceutical Design 2000; 6 (6) . https://dx.doi.org/10.2174/1381612003400641
DOI https://dx.doi.org/10.2174/1381612003400641 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy The Role of SHP-2 in Cell Signalling and Human Disease
Current Enzyme Inhibition Increased Expression of the Remodeling- and Tumorigenic-Associated Factor Osteopontin in Pyramidal Neurons of the Alzheimers Disease Brain
Current Alzheimer Research Formulated Squalene for Food Related Applications
Recent Patents on Food, Nutrition & Agriculture Preface
Current Pharmaceutical Design Pericyte: Potential Target for Hemorrhagic Stroke Prevention and Treatment
Current Drug Delivery Recent Progress in the Development of Selective TRPV1 Antagonists for Pain
Current Topics in Medicinal Chemistry Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives
Current Pharmaceutical Design Selected Phytochemicals to Combat Lungs Injury: Natural Care
Combinatorial Chemistry & High Throughput Screening Dibenzylbutyrolactone Lignans – A Review of Their Structural Diversity, Biosynthesis, Occurrence, Identification and Importance
Mini-Reviews in Medicinal Chemistry Gene-Based Therapies for Dominant Retinopathies
Current Gene Therapy Effects of Erythropoietin on Brain Function
Current Pharmaceutical Biotechnology Edible Medicinal Plants on Facilitating Childbirth: A Systematic Review
Current Drug Discovery Technologies Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies
Current Drug Metabolism Endogenous Ligand Bias by Chemokines: Implications at the Front Lines of Infection and Leukocyte Trafficking
Endocrine, Metabolic & Immune Disorders - Drug Targets Distribution of Chloroaluminum Phthalocyanine in a Lipid Nano-Emulsion as Studied by Second-Derivative Spectrophotometry
Micro and Nanosystems New Approaches in the Management of Septic Shock
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4
Current Drug Metabolism Oncostatin M: Potential Implications for Malignancy and Metabolism
Current Pharmaceutical Design Discovery of Small Molecule Inhibitors for Prevention of Complement- Mediated Immune Hemolysis
Drug Design Reviews - Online (Discontinued)